ELUSYS THERAPEUTICS INC FKA NIGHTHAWK BIOSCIENCES, INC.
Therapeutic Anthrax Treatment Development
The register keeps a separate record of this client for every firm that files for it and every spelling of its name. All 6 of its records are shown together here.
Reported lobbying by year
Filings
| Filing | Filed by | Amount |
|---|---|---|
|
3rd Quarter - Report 3rd Quarter 2026
|
ELUSYS THERAPEUTICS INC FKA NIGHTHAWK BIOSCIENCES, INC. | $260,000 reported |
|
3rd Quarter - Report 3rd Quarter 2026
|
THE CONAFAY GROUP, LLC | $20,000 reported |
|
2nd Quarter - Report 2nd Quarter 2026
|
THE CONAFAY GROUP, LLC | $20,000 reported |
|
2nd Quarter - Report 2nd Quarter 2026
|
ELUSYS THERAPEUTICS INC FKA NIGHTHAWK BIOSCIENCES, INC. | $280,000 reported |
|
1st Quarter - Report 1st Quarter 2026
|
ELUSYS THERAPEUTICS INC FKA NIGHTHAWK BIOSCIENCES, INC. | $220,000 reported |
|
1st Quarter - Report 1st Quarter 2026
|
THE CONAFAY GROUP, LLC | $20,000 reported |
|
4th Quarter - Report 4th Quarter 2025
|
ELUSYS THERAPEUTICS INC FKA NIGHTHAWK BIOSCIENCES, INC. | $200,000 reported |
|
4th Quarter - Report 4th Quarter 2025
|
THE CONAFAY GROUP, LLC | $20,000 reported |
|
3rd Quarter - Report 3rd Quarter 2025
|
ELUSYS THERAPEUTICS INC FKA NIGHTHAWK BIOSCIENCES, INC. | $150,000 reported |
|
3rd Quarter - Report 3rd Quarter 2025
|
THE CONAFAY GROUP, LLC | $20,000 reported |
Filed by
Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.
| Firm | Reports | Amount |
|---|---|---|
| ELUSYS THERAPEUTICS INC FKA NIGHTHAWK BIOSCIENCES, INC. | 14 | $2,420,000 |
| CORNERSTONE GOVERNMENT AFFAIRS, INC. | 24 | $720,000 |
| THE CONAFAY GROUP, LLC | 8 | $160,000 |
| MCDERMOTT WILL & SCHULTE LLP | 7 | $110,000 |
| DUTKO WORLDWIDE, LLC | 2 | $60,000 |
| EDWARDS WILDMAN PALMER LLP | 4 | $50,000 |
Issues lobbied
How many report sections named each issue, counting the current version of each report.
| Issue | Code | Mentions |
|---|---|---|
| Budget/Appropriations | BUD | 26 |
| Health Issues | HCR | 23 |
| Medical/Disease Research/Clinical Labs | MED | 17 |
| Defense | DEF | 15 |
Bills named in its filings
Bill numbers found in the filers' descriptions, most often named first.
| Bill | Congress | Times named |
|---|---|---|
| H.R. 2707 | 119th | 14 |
| H.R. 2882 | 118th | 8 |
| H.R. 4421 | 118th | 8 |
| H.R. 2670 | 118th | 8 |
| S. 2333 | 118th | 8 |
| S. 2587 | 119th | 6 |
| H.R. 3838 | 119th | 6 |
| S. 1855 | 112th | 5 |
| H.R. 2405 | 112th | 5 |
| H.R. 9260 | 119th | 4 |
| H.R. 5304 | 119th | 4 |
| H.R. 8800 | 119th | 4 |
| H.R. 4016 | 119th | 4 |
| S. 4784 | 119th | 4 |
| S. 2572 | 119th | 4 |
| H.R. 9010 | 119th | 4 |
| H.R. 9495 | 119th | 4 |
From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.